265 related articles for article (PubMed ID: 33537216)
1. Liposomes: Biomedical Applications.
Kim EM; Jeong HJ
Chonnam Med J; 2021 Jan; 57(1):27-35. PubMed ID: 33537216
[TBL] [Abstract][Full Text] [Related]
2. Advances and Challenges of Liposome Assisted Drug Delivery.
Sercombe L; Veerati T; Moheimani F; Wu SY; Sood AK; Hua S
Front Pharmacol; 2015; 6():286. PubMed ID: 26648870
[TBL] [Abstract][Full Text] [Related]
3. Approaches to Address PK-PD Challenges of Conventional Liposome Formulation with Special Reference to Cancer, Alzheimer's, Diabetes, and Glaucoma: An Update on Modified Liposomal Drug Delivery System.
Kesharwani P; Kumari K; Gururani R; Jain S; Sharma S
Curr Drug Metab; 2022; 23(9):678-692. PubMed ID: 35692131
[TBL] [Abstract][Full Text] [Related]
4. Design of liposomes as drug delivery system for therapeutic applications.
Guimarães D; Cavaco-Paulo A; Nogueira E
Int J Pharm; 2021 May; 601():120571. PubMed ID: 33812967
[TBL] [Abstract][Full Text] [Related]
5. Engineered Liposomes in Interventional Theranostics of Solid Tumors.
Kommineni N; Chaudhari R; Conde J; Tamburaci S; Cecen B; Chandra P; Prasad R
ACS Biomater Sci Eng; 2023 Aug; 9(8):4527-4557. PubMed ID: 37450683
[TBL] [Abstract][Full Text] [Related]
6. Diagnostic and therapeutic evaluation of folate-targeted paclitaxel and vinorelbine encapsulating theranostic liposomes for non-small cell lung cancer.
Karpuz M; Silindir-Gunay M; Ozer AY; Ozturk SC; Yanik H; Tuncel M; Aydin C; Esendagli G
Eur J Pharm Sci; 2021 Jan; 156():105576. PubMed ID: 32987115
[TBL] [Abstract][Full Text] [Related]
7. Liposomal antibiotics for the treatment of infectious diseases.
Alhariri M; Azghani A; Omri A
Expert Opin Drug Deliv; 2013 Nov; 10(11):1515-32. PubMed ID: 23886421
[TBL] [Abstract][Full Text] [Related]
8. Determining critical parameters that influence in vitro performance characteristics of a thermosensitive liposome formulation of vinorelbine.
Regenold M; Steigenberger J; Siniscalchi E; Dunne M; Casettari L; Heerklotz H; Allen C
J Control Release; 2020 Dec; 328():551-561. PubMed ID: 32896612
[TBL] [Abstract][Full Text] [Related]
9. Methods of Liposomes Preparation: Formation and Control Factors of Versatile Nanocarriers for Biomedical and Nanomedicine Application.
Lombardo D; Kiselev MA
Pharmaceutics; 2022 Feb; 14(3):. PubMed ID: 35335920
[TBL] [Abstract][Full Text] [Related]
10. Liposomal formulations of poorly soluble camptothecin: drug retention and biodistribution.
Flaten GE; Chang TT; Phillips WT; Brandl M; Bao A; Goins B
J Liposome Res; 2013 Mar; 23(1):70-81. PubMed ID: 23210622
[TBL] [Abstract][Full Text] [Related]
11. Cancer stem cells-emanated therapy resistance: Implications for liposomal drug delivery systems.
Dianat-Moghadam H; Heidarifard M; Jahanban-Esfahlan R; Panahi Y; Hamishehkar H; Pouremamali F; Rahbarghazi R; Nouri M
J Control Release; 2018 Oct; 288():62-83. PubMed ID: 30184466
[TBL] [Abstract][Full Text] [Related]
12. Biopolymer-liposome hybrid systems for controlled delivery of bioactive compounds: Recent advances.
Tan C; Wang J; Sun B
Biotechnol Adv; 2021; 48():107727. PubMed ID: 33677025
[TBL] [Abstract][Full Text] [Related]
13. The liposomal formulation of doxorubicin.
Abraham SA; Waterhouse DN; Mayer LD; Cullis PR; Madden TD; Bally MB
Methods Enzymol; 2005; 391():71-97. PubMed ID: 15721375
[TBL] [Abstract][Full Text] [Related]
14. Liposomal drug delivery systems: an update review.
Samad A; Sultana Y; Aqil M
Curr Drug Deliv; 2007 Oct; 4(4):297-305. PubMed ID: 17979650
[TBL] [Abstract][Full Text] [Related]
15. The use of liposomal anticancer agents to determine the roles of drug pharmacodistribution and P-glycoprotein (PGP) blockade in overcoming multidrug resistance (MDR).
Krishna R; Mayer LD
Anticancer Res; 1999; 19(4B):2885-91. PubMed ID: 10652569
[TBL] [Abstract][Full Text] [Related]
16. Design of multifunctional liposome-quantum dot hybrid nanocarriers and their biomedical application.
Qu W; Zuo W; Li N; Hou Y; Song Z; Gou G; Yang J
J Drug Target; 2017 Sep; 25(8):661-672. PubMed ID: 28438041
[TBL] [Abstract][Full Text] [Related]
17. A targeted liposome delivery system for combretastatin A4: formulation optimization through drug loading and in vitro release studies.
Nallamothu R; Wood GC; Kiani MF; Moore BM; Horton FP; Thoma LA
PDA J Pharm Sci Technol; 2006; 60(3):144-55. PubMed ID: 17089683
[TBL] [Abstract][Full Text] [Related]
18. Liposome encapsulation of zoledronic acid results in major changes in tissue distribution and increase in toxicity.
Shmeeda H; Amitay Y; Tzemach D; Gorin J; Gabizon A
J Control Release; 2013 May; 167(3):265-75. PubMed ID: 23419948
[TBL] [Abstract][Full Text] [Related]
19. Magnetic Heating Stimulated Cargo Release with Dose Control using Multifunctional MR and Thermosensitive Liposome.
Ray S; Cheng CA; Chen W; Li Z; Zink JI; Lin YY
Nanotheranostics; 2019; 3(2):166-178. PubMed ID: 31183312
[No Abstract] [Full Text] [Related]
20. Liposomes as Versatile Platform for Cancer Theranostics: Therapy, Bio-imaging, and Toxicological Aspects.
Mehta S; Kulkarni S; Nikam AN; Padya BS; Pandey A; Mutalik S
Curr Pharm Des; 2021; 27(17):1977-1991. PubMed ID: 33719968
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
